Photo courtesy of iStockphoto, shannon drawe
Earlier this week, the FDA has announced its approved flu vaccines for the 2008-2009 flu season in the United States.

Six vaccines approved and their manufacturers are:

Afluria by CSL Limited
Fluarix by GlaxoSmithKline Biologicals
FluLaval by ID Biomedical Corporation of Quebec
FluMist by MedImmune Vaccines Inc.
Fluvirin by Novartis Vaccines and Diagnostics Limited
Fluzone by Sanofi Pasteur Inc.

This season's vaccines contain three strains of the influenza virus that disease experts expect to be the most likely cause of the flu in the United States.

Each season's vaccines are modified to reflect the virus strains most likely to be circulating. The closer the match between the circulating strains and the strains in the vaccines, the better the protection.

Read more from the FDA News.

See full article.

Related Entries:

The Netherlands Invested Euro 18.4 Million to Make Better Vaccines to Fight Raging TB Pandemic - 07 November 2006

Modified Akt1 Enzyme Boost Efficacy of Tumor Vaccines - 05 December 2006

Beware of Poory Refrigerated Vaccines - 04 December 2007

Contents of this feed are a property of Creative Weblogging Limited and are protected by copyright laws. Violations will be prosecuted. Please email us if you'd like to use this feed for non-commercial activities at feeds - at - creative-weblogging.com.